School of Medicine and Public Health, Department of Medical Physics, University of Wisconsin-Madison, Madison, Wisconsin, USA.
J Appl Clin Med Phys. 2019 Aug;20(8):122-133. doi: 10.1002/acm2.12687. Epub 2019 Jul 29.
End-to-end testing with quality assurance (QA) phantoms for deformable dose accumulation and real-time image-guided radiotherapy (IGRT) has recently been recommended by American Association of Physicists in Medicine (AAPM) Task Groups 132 and 76. The goal of this work was to develop a deformable abdominal phantom containing a deformable three-dimensional dosimeter that could provide robust testing of these systems.
The deformable abdominal phantom was fabricated from polyvinyl chloride plastisol and phantom motion was simulated with a programmable motion stage and plunger. A deformable normoxic polyacrylamide gel (nPAG) dosimeter was incorporated into the phantom apparatus to represent a liver tumor. Dosimeter data were acquired using magnetic resonance imaging (MRI). Static measurements were compared to planned dose distributions. Static and dynamic deformations were used to simulate inter- and intrafractional motion in the phantom and measurements were compared to baseline measurements.
The statically irradiated dosimeters matched the planned dose distribution with an average γ pass rates of 97.0 ± 0.5% and 97.5 ± 0.2% for 3%/5 mm and 5%/5 mm criteria, respectively. Static deformations caused measured dose distribution shifts toward the phantom plunger. During the dynamic deformation experiment, the dosimeter that utilized beam gating showed an improvement in the γ pass rate compared to the dosimeter that did not.
A deformable abdominal phantom apparatus which incorporates a deformable nPAG dosimeter was developed to test real-time IGRT systems and deformable dose accumulation algorithms. This apparatus was used to benchmark simple static irradiations in which it was found that measurements match well to the planned distributions. Deformable dose accumulation could be tested by directly measuring the shifts and blurring of the target dose due to interfractional organ deformation and motion. Dosimetric improvements were achieved from the motion management during intrafractional motion.
美国医学物理学家协会(AAPM)工作组 132 和 76 最近建议对可变形剂量积累和实时图像引导放射治疗(IGRT)进行端到端测试,并进行质量保证(QA)。这项工作的目的是开发一种包含可变形三维剂量计的可变形腹部体模,该体模可对这些系统进行稳健测试。
可变形腹部体模由聚氯乙烯糊制成,通过可编程运动台和柱塞模拟体模运动。将可变形常氧聚丙烯酰胺凝胶(nPAG)剂量计纳入体模装置以代表肝肿瘤。使用磁共振成像(MRI)获取剂量计数据。将静态测量值与计划的剂量分布进行比较。静态和动态变形用于模拟体模内和分次内运动,并将测量值与基线测量值进行比较。
静态辐射的剂量计与计划的剂量分布相匹配,3%/5mm 和 5%/5mm 标准下的平均γ通过率分别为 97.0±0.5%和 97.5±0.2%。静态变形导致测量的剂量分布向体模柱塞移动。在动态变形实验中,与未使用束流门控的剂量计相比,使用束流门控的剂量计的γ通过率有所提高。
开发了一种可变形腹部体模装置,该装置包含可变形 nPAG 剂量计,用于测试实时 IGRT 系统和可变形剂量积累算法。该装置用于基准测试简单的静态照射,发现测量结果与计划分布非常吻合。通过直接测量由于分次间器官变形和运动导致的靶剂量的移位和模糊,可以测试可变形剂量积累。在分次内运动期间通过运动管理实现了剂量学的改善。